What is Intent Solutions?
Based in Atlanta, Intent Solutions operates at the intersection of software engineering and pharmaceutical safety. The company specializes in mitigating the risks associated with the misuse, abuse, and diversion of prescription medications, particularly opioids. Their flagship product, tadtm, serves as a sophisticated platform for the secure delivery of medicine, providing researchers and clinicians with granular insights into patient adherence. By integrating smart technology into the medication delivery process, Intent Solutions addresses a critical gap in clinical trial management, ensuring that data integrity is maintained through enhanced patient monitoring and secure, automated dispensing protocols.
How much funding has Intent Solutions raised?
Intent Solutions has raised a total of $4.2M across 2 funding rounds:
Angel/Seed
$1.5M
Private Equity
$2.7M
Angel/Seed (2016): $1.5M, investors not publicly disclosed
Private Equity (2017): $2.7M, investors not publicly disclosed
Key Investors in Intent Solutions
Undisclosed Investor
An institutional capital provider focused on scaling high-growth technology firms within the healthcare and life sciences sectors.
Undisclosed Investor
A strategic investment partner specializing in early-stage medical technology and digital health innovation.
Undisclosed Investor
A specialized firm dedicated to supporting advancements in medication safety and clinical trial infrastructure.
What's next for Intent Solutions?
With this recent infusion of capital, Intent Solutions is well-positioned to scale its enterprise-level operations and expand the reach of its tadtm platform. The company is expected to prioritize the integration of advanced data analytics to further refine its adherence insights, catering to the growing demand for robust clinical trial oversight. As the regulatory environment surrounding prescription medication becomes increasingly stringent, Intent Solutions' focus on secure, technology-driven delivery systems provides a competitive moat. Future strategic initiatives will likely involve deepening partnerships with large-scale clinical research organizations and expanding their footprint in the broader pharmaceutical supply chain, ensuring that their technology remains the gold standard for medication safety and patient compliance monitoring.
See full Intent Solutions company page
